Become part of the CDDF community working together to find ways to accelerate oncology drug development and deliver optimal treatment to cancer patients
CDDF has developed a community of stakeholders who support our shared mission to facilitate debate and progress in the field of oncology drug development. Non-commercial organisations (academia, NGOs and associations), pharmaceutical companies, regulatory agencies and individuals in the community of cancer research can join the CDDF network and collaborate with us. The CDDF believes that collaboration is key to overcome challenges in the development of cancer drugs. By establishing a multi-stakeholder network and working together constructively we can achieve our goal to increase efficiency in cancer drug development and accelerate the delivery of effective oncology treatment to patients.
We thank CDDF members and the following partners for their continuing support.
CDDF collaborates with representatives from regulatory authorities to obtain their views on drug development.
PHARMACEUTICAL INDUSTRY PARTNERS
CDDF pharmaceutical industry partners provide the industry perspective on challenges to be addressed in cancer drug development.
CDDF has established close cooperation with the following organizations whose missions are in line with CDDF’s.
PATIENT ADVOCACY GROUPS
CDDF works closely with patient advocacy groups to incorporate the patient perspective into our discussion.